Radiolab
Also in Science
Science
GRACEcast Radiation Oncology Audio
by cancerGRACE - H. Jack West, MD
Today: #53 in Science, India on our combined chart.
Share this ranking
Claiming needs an RSS feed. Contact us.
Chart positions today · Ireland
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like GRACEcast Radiation Oncology Audio, try…
Oncology Today with Dr Neil Love
Similar topics: oncology
Simply Oncology
Similar topics: oncology and cancer
CME in Minutes: Education in Oncology & Hematology
Similar topics: oncology and education
On Target
Similar topics: radiation and cancer
Managed Care Cast
Similar topics: oncology and advancing
Ranking history · Ireland
No ranking history for this show in Ireland over the last 7 days.
Latest episodes
-
Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy?
July 31, 2014 · 5 minDr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.
-
Management of Rare Kidney Tumors
July 29, 2014 · 2 minWhat puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for to determine if a kidney cancer patient should be screened for a familial syndrome.
-
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation?
July 27, 2014 · 5 minThe doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.
-
NanoString Treatment for Kidney Cancer
July 24, 2014 · 2 minNanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and, therefore, determine what treatments may be most effective for them.
-
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?
July 22, 2014 · 2 minDr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
Show 7 more episodesShow fewer episodes
-
How is the Heng Criteria Applied to Kidney Cancer Patients?
July 20, 2014 · 5 minDr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer patients to determine their prognoses.
-
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment?
July 17, 2014 · 7 minThe REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.
-
What is PD1 and PDL1 in Kidney Cancer?
July 15, 2014 · 3 minDr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
-
Zykadia for ALK Positive Lung Cancer: New Drug, New Hope
July 13, 2014 · 7 minThe doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.
-
No Clear Answer for Non-Clear Cell Kidney Cancer
July 10, 2014 · 6 minDrugs in early stage clinical trials seem to show benefit for non-clear cell kidney cancer, but more trials must take place and patients are desperately needed to enroll in them.
-
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer
July 8, 2014 · 4 min"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).
-
Treating Newly Diagnosed Kidney Cancer
July 6, 2014 · 3 minDr. Guru Sonpavde discusses what he does when he first begins treating a patient recently diagnosed with late stage kidney cancer.
About the show
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.